Brandes Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-745,080
| Closed | -$3.9M | – | 193 |
|
2023
Q4 | $3.9M | Sell |
745,080
-389,283
| -34% | -$2.04M | 0.06% | 118 |
|
2023
Q3 | $17.9M | Buy |
1,134,363
+293,276
| +35% | +$4.62M | 0.35% | 75 |
|
2023
Q2 | $16.4M | Buy |
841,087
+296,037
| +54% | +$5.75M | 0.33% | 77 |
|
2023
Q1 | $15.5M | Buy |
545,050
+128,873
| +31% | +$3.66M | 0.33% | 73 |
|
2022
Q4 | $12.2M | Sell |
416,177
-51,680
| -11% | -$1.51M | 0.34% | 59 |
|
2022
Q3 | $12.4M | Buy |
467,857
+3,565
| +0.8% | +$94.2K | 0.32% | 76 |
|
2022
Q2 | $20.6M | Buy |
464,292
+32,442
| +8% | +$1.44M | 0.5% | 54 |
|
2022
Q1 | $21.4M | Sell |
431,850
-182,515
| -30% | -$9.03M | 0.46% | 61 |
|
2021
Q4 | $31.3M | Sell |
614,365
-58,711
| -9% | -$2.99M | 0.68% | 48 |
|
2021
Q3 | $37.5M | Sell |
673,076
-43,797
| -6% | -$2.44M | 0.81% | 42 |
|
2021
Q2 | $30.7M | Buy |
716,873
+227,246
| +46% | +$9.73M | 0.68% | 48 |
|
2021
Q1 | $20.1M | Buy |
489,627
+225,230
| +85% | +$9.25M | 0.48% | 60 |
|
2020
Q4 | $12.3M | Buy |
264,397
+109,473
| +71% | +$5.09M | 0.32% | 73 |
|
2020
Q3 | $6.58M | Buy |
154,924
+147,833
| +2,085% | +$6.28M | 0.23% | 81 |
|
2020
Q2 | $340K | Sell |
7,091
-143,510
| -95% | -$6.88M | 0.01% | 146 |
|
2020
Q1 | $6.93M | Buy |
150,601
+145,413
| +2,803% | +$6.69M | 0.24% | 80 |
|
2019
Q4 | $312K | Buy |
5,188
+57
| +1% | +$3.43K | 0.01% | 126 |
|
2019
Q3 | $290K | Sell |
5,131
-2,262
| -31% | -$128K | 0.01% | 123 |
|
2019
Q2 | $412K | Sell |
7,393
-14,585
| -66% | -$813K | 0.01% | 117 |
|
2019
Q1 | $1.11M | Buy |
21,978
+668
| +3% | +$33.7K | 0.03% | 106 |
|
2018
Q4 | $858K | Buy |
21,310
+17,652
| +483% | +$711K | 0.02% | 117 |
|
2018
Q3 | $254K | Sell |
3,658
-8,327
| -69% | -$578K | 0.01% | 135 |
|
2018
Q2 | $907K | Sell |
11,985
-13,234
| -52% | -$1M | 0.02% | 111 |
|
2018
Q1 | $1.33M | Buy |
+25,219
| New | +$1.33M | 0.03% | 117 |
|